Skip to main navigation
Skip to search
Skip to main content
Hong Kong Baptist University Home
Help & FAQ
Link opens in a new tab
Search content at Hong Kong Baptist University
Home
Scholars
Departments / Units
Research Output
Projects / Grants
Prizes / Awards
Activities
Press/Media
Student theses
Datasets
Emerging pharmacotherapy for inflammatory bowel diseases
Hua Luo
, Guiqing Cao
, Chun Luo
, Dechao Tan
, Chi Teng Vong
, Yinyue Xu
, Sicen Wang
,
Haitao Lu
*
, Yitao Wang
*
, Wanghui Jing
*
*
Corresponding author for this work
Chinese Medicine - Teaching and Research Division
Centre for Chinese Herbal Medicine Drug Development Limited
Research output
:
Contribution to journal
›
Review article
›
peer-review
99
Citations (Scopus)
Overview
Fingerprint
Fingerprint
Dive into the research topics of 'Emerging pharmacotherapy for inflammatory bowel diseases'. Together they form a unique fingerprint.
Sort by:
Weight
Alphabetically
Keyphrases
Inflammatory Bowel Disease
100%
Emerging Pharmacotherapy
100%
Pharmacotherapy
20%
Intestinal Microorganisms
20%
Targeted Drug Delivery
20%
Genetic Modification
20%
Putative Drug Targets
20%
Environmental Impact
20%
Ulcerative Colitis
20%
Clinical Treatment
20%
Microbial Metabolites
20%
Novel Therapeutics
20%
Innovative Therapies
20%
Antibiotics
20%
Fecal Microbiota Transplantation
20%
Gut Dysbiosis
20%
Drug Efficacy
20%
Crohn's Disease
20%
Clinical Remission
20%
Host Immune Response
20%
Advanced Drug Delivery Systems
20%
Drug Safety
20%
Chronic Intestinal Inflammation
20%
Biological Agents
20%
Healthy Tissue
20%
Intestinal Function
20%
Immune Dysfunction
20%
Mucosal Ulcers
20%
Probiotic Metabolites
20%
Etiopathogenesis
20%
Pharmacology, Toxicology and Pharmaceutical Science
Pharmacotherapy
100%
Inflammatory Bowel Disease
100%
Drug Delivery System
20%
Microorganism
20%
Ulcerative Colitis
20%
Antibiotics
20%
Ulcer
20%
Dysbiosis
20%
Enteritis
20%
Crohn's Disease
20%
Feces microflora
20%
Remission
20%
Side Effect
20%